Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism

Published:2022-06 Issue:6 Volume:20 Page:1376-1384
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Bistervels Ingrid M.^ORCID,Bavalia Roisin^ORCID,Gebel Martin,Lensing Anthonie W.A.,Middeldorp Saskia^ORCID,Prins Martin H.,Coppens Michiel^ORCID

Publisher

Elsevier BV

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15692

Reference14 articles.

1. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN‐DVT and PE randomized studies;Prins;Thromb J,2013

2. Frequency of and risk factors for preventable medication‐related hospital admissions in the Netherlands;Leendertse;Arch Intern Med,2008

3. Drug‐drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study;Teklay;Thromb J,2014

4. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence‐based clinical practice guidelines (8th Edition);Ansell;Chest,2008

5. Polypharmacy and the efficacy and safety of rivaroxaban versus warfarin in the prevention of stroke in patients with nonvalvular atrial fibrillation;Piccini;Circulation,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral anticoagulant therapy in older adults;Thrombosis Research;2024-06

2. Effect of Diosmin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Rats;Current Pharmaceutical Analysis;2024-05

3. Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis;Current Pharmaceutical Design;2024-04

4. Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data;European Journal of Clinical Pharmacology;2023-10-10

5. Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention;Circulation Journal;2023-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3